Medulloblastoma simulating acute myeloid leukemia: Case report with a review of "myeloid antigen" expression in nonhematopoietic tissues and tumors

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 11, 2006, Pages 703-710

  Etzell, Joan E ^a,b   Keet, Corinne ^c   McDonald, William ^b   Banerjee, Anuradha ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Acute myeloid leukemia; Flow cytometry; Immunophenotyping; Medulloblastoma; Myeloid antigens; Primitive neuroectodermal tumor; Small round blue cell tumor

Indexed keywords

CD15 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; TUMOR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANEMIA; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CEREBELLUM TUMOR; CEREBROSPINAL FLUID ANALYSIS; FEMALE; FLOW CYTOMETRY; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPENIA; MEDULLOBLASTOMA; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SIMULATION; TISSUE DISTRIBUTION; TUMOR CELL;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, NEOPLASM; BONE MARROW NEOPLASMS; BONE NEOPLASMS; CEREBELLAR NEOPLASMS; FATAL OUTCOME; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID; MEDULLOBLASTOMA;

EID: 33751218908     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000243647.66734.0f     Document Type: Article

References (34)

1. Kleinman GM, Hochberg FH, Richardson EP Jr. Systemic metastases from medulloblastoma: report of two cases and review of the literature. Cancer. 1981;48:2296-2309.
2. Rochkind S, Blatt I, Sadeh M, et al. Extracranial metastases of medulloblastoma in adults: literature review. J Neurol Neurosurg Psychiatry. 1991;54:80-86.
3. Pollak ER, Miller HJ, Vye MV. Medulloblastoma presenting as leukemia. Am J Clin Pathol. 1981;76:98-103.
4. Chu JY. Metastatic medulloblastoma simulating acute leukemia. J Pediatr. 1979;94:921-923.
5. Bach M, Simpson WJ, Platts ME. Metastatic cerebellar sarcoma (desmoplastic medulloblastoma) with diffuse osteosclerosis and leukoerythroblastic anemia. Am J Roentgenol Radium Ther Nucl Med. 1968;103:38-43.
6. Bryson GJ, Lear D, Williamson R, et al. Detection of the CD56+/CD45- immunophenotype by flow cytometry in neuroendocrine malignancies. J Clin Pathol. 2002;55:535-537.
7. Gardner LJ, Polski JM, Fallon R, et al. Identification of CD56 and CD57 by flow cytometry in Ewing's sarcoma or primitive neuroectodermal tumor. Virchows Arch. 1998;433:35-40.
8. Dunphy CH. Contribution of flow cytometric immunophenotyping to the evaluation of tissues with suspected lymphoma? Cytometry. 2000;42:296-306.
9. Konemann S, Schuck A, Malath J, et al. Cell heterogeneity and subpopulations in solid tumors characterized by simultaneous immunophenotyping and DNA content analysis. Cytometry. 2000;41:172-177.
10. Ricotti E, Fagioli F, Garelli E, et al. c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells. Blood. 1998;91:2397-2405.
11. Chan AW, Tarbell NJ, Black PM, et al. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery. 2000;47:623-631; discussion 631-632.
12. Barai S, Bandopadhayaya GP, Julka PK, et al. Cerebellar medulloblastoma presenting with skeletal metastasis. J Postgrad Med. 2004;50:110-112.
13. Eberhart CG, Cohen KJ, Tihan T, et al. Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol. 2003;25:198-203.
14. Nakamura A, Tsurusawa M, Kato A, et al. Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia. Leuk Lymphoma. 2001;42:393-398.
15. Ratei R, Sperling C, Karawajew L, et al. Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. Ann Hematol. 1998;77:107-114.
16. Khalidi HS, Chang KL, Medeiros LJ, et al. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. Am J Clin Pathol. 1999;111:467-476.
17. Khalidi HS, Medeiros LJ, Chang KL, et al. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am J Clin Pathol. 1998;109:211-220.
18. Chang A, Benda PM, Wood BL, et al. Lineage-specific identification of nonhematopoietic neoplasms by flow cytometry. Am J Clin Pathol. 2003;119:643-655.
19. Farinola MA, Weir EG, Ali SZ. CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy. Cancer. 2003;99:240-246.
20. Leon ME, Hou JS, Galindo LM, et al. Fine-needle aspiration of adult small-round-cell tumors studied with flow cytometry. Diagn Cytopathol. 2004;31:147-154.
21. Son EI, Kim IM, Kim DW, et al. Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas. Pathol Int. 2003;53:67-73.
22. Komada Y, Zhang XL, Zhou YW, et al. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma. Cancer. 1998;82:591-599.
23. Warzynski MJ, Graham DM, Axtell RA, et al. Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients. Cytometry. 2002;50:298-304.
24. Okcu MF, Wang RY, Bueso-Ramos C, et al. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow. Pediatr Blood Cancer. 2005;45:787-795.
25. Dixon J, Kaklamanis L, Turley H, et al. Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol. 1994;47:43-47.
26. Riemann D, Kehlen A, Langner J. CD13 - not just a marker in leukemia typing. Immunol Today. 1999;20:83-88.
27. Curnis F, Arrigoni G, Sacchi A, et al. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res. 2002;62:867-874.
28. Noble F, Banisadr G, Jardinaud F, et al. First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [125I]RB 129. Neuroscience. 2001;105:479-488.
29. Davidson SE, McKenzie JL, Beard ME, et al. The tissue distribution of the 3 alpha-fucosyl-N-acetyl lactosamine determinant recognized by the CD15 monoclonal antibodies CMRF-7 and 27. Pathology. 1988;20:24-31.
30. Klassen H, Schwartz MR, Bailey AH, et al. Surface markers expressed by multipotent human and mouse neural progenitor cells include tetraspanins and non-protein epitopes. Neurosci Lett. 2001;312:180-182.
31. Reifenberger G, Sieth P, Niederhaus M, et al. Expression of CD15 in tumours of the nervous system. Histochem J. 1992;24:890-901.
32. Smithey BE, Pappo AS, Hill DA. C-kit expression in pediatric solid tumors: a comparative immunohistochemical study. Am J Surg Pathol. 2002;26:486-492.
33. Voigt A, Hafer R, Gruhn B, et al. Expression of CD34 and other haematopoietic antigens on neuroblastoma cells: consequences for autologous bone marrow and peripheral blood stem cell transplantation. J Neuroimmunol. 1997;78:117-126.
34. Donovan J, Temel J, Zuckerman A, et al. CD34 selection as a stem cell purging strategy for neuroblastoma: preclinical and clinical studies. Med Pediatr Oncol. 2000;35:677-682.